Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziding Feng

Showing results (161-170 of 288) with videos related to

Pageof 29
Sort By:
Journal of the National Cancer Institute|May 7, 2010
Re: Lung cancer risk among female textile workers exposed to endotoxinGeorge Astrakianakis, Noah S Seixas, Roberta Ray, et al.
Journal of the National Cancer Institute|March 8, 2007
Lung cancer risk among female textile workers exposed to endotoxinGeorge Astrakianakis, Noah S Seixas, Roberta Ray, et al.
Plos Genetics|April 1, 2020
DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPsJames Y Dai, Xiaoyu Wang, Bo Wang, et al.
Urologic Oncology|July 31, 2004
The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncologyWilliam E Grizzle, O John Semmes, Joseph Basler, et al.
Biometrics|May 24, 2003
Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality dataYinsheng Qu, Bao-Ling Adam, Mark Thornquist, et al.
The Journal of Urology|April 12, 2005
5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes studyDavid F Penson, Dale McLerran, Ziding Feng, et al.
Immunohorizons|July 19, 2023
Immunoassay Detects Salivary Anti-SSA/Ro-52 Autoantibodies in Seronegative Patients with Primary Sjögren's SyndromeSarah Kamounah, Nabihah Tayob, Samantha Chiang, et al.
European Urology Focus|February 10, 2018
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk CalculatorDonna P Ankerst, Martin Goros, Scott A Tomlins, et al.
BJU International|September 30, 2010
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason scoreYing Huang, Sumit Isharwal, Alexander Haese, et al.
Oncotarget|November 16, 2017
<i>PTEN</i> loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profilesMilan S Geybels, Min Fang, Jonathan L Wright, et al.
Pageof 29

Showing results (161-170 of 288) with videos related to

Sort By:
Pageof 29
Journal of the National Cancer Institute|May 7, 2010
Re: Lung cancer risk among female textile workers exposed to endotoxinGeorge Astrakianakis, Noah S Seixas, Roberta Ray, et al.
Journal of the National Cancer Institute|March 8, 2007
Lung cancer risk among female textile workers exposed to endotoxinGeorge Astrakianakis, Noah S Seixas, Roberta Ray, et al.
Plos Genetics|April 1, 2020
DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPsJames Y Dai, Xiaoyu Wang, Bo Wang, et al.
Urologic Oncology|July 31, 2004
The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncologyWilliam E Grizzle, O John Semmes, Joseph Basler, et al.
Biometrics|May 24, 2003
Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality dataYinsheng Qu, Bao-Ling Adam, Mark Thornquist, et al.
The Journal of Urology|April 12, 2005
5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes studyDavid F Penson, Dale McLerran, Ziding Feng, et al.
Immunohorizons|July 19, 2023
Immunoassay Detects Salivary Anti-SSA/Ro-52 Autoantibodies in Seronegative Patients with Primary Sjögren's SyndromeSarah Kamounah, Nabihah Tayob, Samantha Chiang, et al.
European Urology Focus|February 10, 2018
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk CalculatorDonna P Ankerst, Martin Goros, Scott A Tomlins, et al.
BJU International|September 30, 2010
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason scoreYing Huang, Sumit Isharwal, Alexander Haese, et al.
Oncotarget|November 16, 2017
<i>PTEN</i> loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profilesMilan S Geybels, Min Fang, Jonathan L Wright, et al.
Pageof 29